These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3169110)

  • 1. Studies of the agonist and antagonist activity of cicloprolol in man.
    McCaffrey PM; Burke M; Riddell JG; Shanks RG
    Eur J Clin Pharmacol; 1988; 34(6):569-75. PubMed ID: 3169110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551.
    McCaffrey PM; Riddell JG; Shanks RG
    J Cardiovasc Pharmacol; 1988 May; 11(5):543-51. PubMed ID: 2455840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
    Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog.
    Hadfield SE; Slee SJ; Snow HM
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):78S-81S. PubMed ID: 2572262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectivity of xamoterol, prenalterol and salbutamol as assessed by their effects in the presence and absence of ICI 118 551.
    McCaffrey PM; Riddell JG; Shanks RG
    Eur Heart J; 1990 Apr; 11 Suppl A():54-5. PubMed ID: 1971592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the safety of the beta-modulator cicloprolol in chronic heart failure.
    Cocco G; Alfiero R; Pouleur H
    Clin Cardiol; 1992 Jan; 15(1):38-42. PubMed ID: 1347258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cicloprolol in intraocular pressure in healthy volunteers.
    Mekki QA; Turner P
    Br J Clin Pharmacol; 1988 Jul; 26(1):89-91. PubMed ID: 2904826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
    Silke B; Hanratty CG; Riddell JG
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic without pharmacokinetic interaction between cicloprolol, a partial beta 1-adrenoceptor agonist, and digoxin in healthy subjects.
    Weber S; Kahan A; Pinquier JL; Julien J; Rosenzweig P; Bianchetti G; Morselli PL; Dessault O; De Lauture D; Strauch G
    Br J Clin Pharmacol; 1990 Sep; 30(3):411-6. PubMed ID: 1977438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
    Pringle TH; McNeill AJ; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
    Fitzgerald DE; Harry JD
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease.
    Silke B; Verma SP; Sharma SK; Frais MA; Reynolds G; Taylor SH
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):155-61. PubMed ID: 2468927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacodynamics of dilevalol.
    Riddell JG
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():39-44. PubMed ID: 2370642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effect on heart rate variability of some agents acting at the beta-adrenoceptor using nonlinear scatterplot and sequence methods.
    Silke B; Riddell JG
    Cardiovasc Drugs Ther; 1998 Oct; 12(5):439-48. PubMed ID: 9926274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
    Reid W; Ewing DJ; Harry JD; Smith HJ; Neilson JM; Clarke BF
    Br J Clin Pharmacol; 1987 Apr; 23(4):383-9. PubMed ID: 2883987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol.
    Johnston GD; Finch MB; Shanks RG
    Eur J Clin Pharmacol; 1986; 30(6):649-52. PubMed ID: 3533562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
    O'Connor PC; Arnold JM; Brown AN; Francis RJ; Finch MB; Galloway DB; Harron DW; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.